The therapeutic use of hematopoietic growth factors

被引：10

作者：

Costa, JJ

机构：

[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Allergy & Inflammat, Boston, MA 02215 USA

[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA

[3] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Expt Pathol, Boston, MA 02215 USA

[4] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1998年 / 101卷 / 01期

关键词：

D O I：

10.1016/S0091-6749(98)70185-X

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1 / 6

页数：6

共 22 条

[1] Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures [J].

Anderlini, P ;

Przepiorka, D ;

Seong, D ;

Miller, P ;

Sundberg, J ;

Lichtiger, B ;

Norfleet, F ;

Chan, KW ;

Champlin, R ;

Korbling, M .

TRANSFUSION, 1996, 36 (07) :590-595

[2]

[Anonymous], 1994, J CLIN ONCOL, V12, P2471

[3] Hematopoietic growth factors [J].

Bociek, RG ;

Armitage, JO .

CA-A CANCER JOURNAL FOR CLINICIANS, 1996, 46 (03) :165-+

[4] Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo [J].

Costa, JJ ;

Demetri, GD ;

Harrist, TJ ;

Dvorak, AM ;

Hayes, DF ;

Merica, EA ;

Menchaca, DM ;

Gringeri, AJ ;

Schwartz, LB ;

Galli, SJ .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2681-2686

[5]

COSTA JJ, 1996, PRINCIPLES PRACTICE, P408

[6] REDUCTION BY GRANULOCYTE COLONY-STIMULATING FACTOR OF FEVER AND NEUTROPENIA INDUCED BY CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL LUNG-CANCER [J].

CRAWFORD, J ;

OZER, H ;

STOLLER, R ;

JOHNSON, D ;

LYMAN, G ;

TABBARA, I ;

KRIS, M ;

GROUS, J ;

PICOZZI, V ;

RAUSCH, G ;

SMITH, R ;

GRADISHAR, W ;

YAHANDA, A ;

VINCENT, M ;

STEWART, M ;

GLASPY, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) :164-170

[7] Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy? [J].

Croockewit, AJ ;

Koopmans, PP ;

dePauw, BE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (01) :1-6

[8]

DENZLINGER C, 1993, BLOOD, V81, P2007

[9]

Fraser JK, 1996, SEMIN ONCOL, V23, P2

[10]

Ganser Arnold, 1996, Current Opinion in Oncology, V8, P265

← 1 2 3 →